Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV-1 second-line failure and drug resistance at high-level and low-level viremia in Western Kenya.

AIDS (London, England) - 13 Nov 2018

Kantor Rami, DeLong Allison, Schreier Leeann, Reitsma Marissa, Kemboi Emanuel, Orido Millicent, Obonge Salome, Boinett Robert, Rono Mary, Emonyi Wilfred, Brooks Katie, Coetzer Mia, Buziba Nathan, Hogan Joseph, Diero Lameck

Abstract excerpt

OBJECTIVE: Characterize failure and resistance above and below guidelines-recommended 1000 copies/ml virologic threshold, upon second-line failure. DESIGN: Cross-sectional study. METHODS: Kenyan adults on lopinavir/ritonavir-based second-line were enrolled at AMPATH (Academic Model Providing Access to Healthcare). Charts were reviewed for demographic/clinical characteristics and CD4/viral load were obtained....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lopinavir

Share to pol Gene Products, Human Immunodeficiency Virus

Share to Ritonavir

Share to Treatment Failure

Share to Viremia

Source

Open in PubMed Open full text

Identifiers

PMID: 30134290
DOI: 10.1097/QAD.0000000000001964
PMCID: PMC6984814

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV-1 second-line failure and drug resistance at high-level and low-level viremia in Western Kenya.PMID 30134290Read ↗

HIV type 1 drug resistance patterns among patients failing first and second line antiretroviral therapy in Nairobi, Kenya.Semantic proximity Read ↗

HIV drug resistance mutations among patients failing second-line antiretroviral therapy in Rwanda.Semantic proximity Read ↗

Drug Susceptibility and Resistance Mutations After First-Line Failure in Resource Limited SettingsSemantic proximity Read ↗

Prevalence and factors associated with drug resistance mutations among HIV - 1 patients failing to achieve virological suppression on second line treatment in Tanzania.Semantic proximity Read ↗

Acquired HIV-1 drug resistance to reverse transcriptase and protease inhibitors among people failing antiretroviral therapy in Cameroon and implications for future treatment options.Semantic proximity Read ↗

Prevalence and factors associated with HIV-1 drug resistance mutations in treatment-experienced patients in Nairobi, Kenya: A cross-sectional study.Semantic proximity Read ↗

Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013-2014.Semantic proximity Read ↗

Accumulation of drug resistance and loss of therapeutic options precede commonly used criteria for treatment failure in HIV-1 subtype-C-infected patients.Semantic proximity Read ↗

High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in NamibiaSemantic proximity Read ↗

Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings.Semantic proximity Read ↗

Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART StrategiesSemantic proximity Read ↗

Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.